At BPC, the patient is our primary concern and our total focus
That does not automatically make one better for every patient
The full impact these medications will have on retail returns remains to be seen
This creates more controllable conditions for subsequent OI or ART, rather than serving as a direct means to induce ovulation or guarantee pregnancy. 8.2 Stratified clinical strategies by phenotype and reproductive intent As evidence for metabolic benefits currently outweighs that for hard ART endpoints, treatment decisions should be stratified by metabolic risk and the reproductive timeline
Combining genetic insights with biomarker monitoring (fasting glucose, insulin levels, lipid panels) and clinical response observation creates a more informed conversation with your provider about whether your weight loss trajectory aligns with expectations or warrants protocol adjustments
If you have OSA, ask your doctor if FDA-approved Zepbound might be a better fit
